Cargando…
Design, Synthesis, and Biological Evaluation of Novel Pyridine-Bridged Analogues of Combretastatin-A4 as Anticancer Agents
[Image: see text] A series of novel pyridine-bridged analogues of combretastatin-A4 (CA-4) were designed and synthesized. As expected, the 4-atom linker configuration retained little cytotoxicities in the compounds 2e, 3e, 3g, and 4i. Activities of the analogues with 3-atom linker varied widely depe...
Autores principales: | Zheng, Shilong, Zhong, Qiu, Mottamal, Madhusoodanan, Zhang, Qiang, Zhang, Changde, LeMelle, Elise, McFerrin, Harris, Wang, Guangdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4002123/ https://www.ncbi.nlm.nih.gov/pubmed/24669888 http://dx.doi.org/10.1021/jm500002k |
Ejemplares similares
-
Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents
por: Mottamal, Madhusoodanan, et al.
Publicado: (2015) -
Modification and Biological
Evaluation of Thiazole
Derivatives as Novel Inhibitors of Metastatic Cancer Cell Migration
and Invasion
por: Zheng, Shilong, et al.
Publicado: (2014) -
Development of Combretastatin A-4 Analogues as Potential Anticancer Agents with Improved Aqueous Solubility
por: Chen, Zhi-Hao, et al.
Publicado: (2023) -
Design, Synthesis, and Evaluation of Niclosamide Analogs as Therapeutic Agents for Enzalutamide-Resistant Prostate Cancer
por: Kang, Borui, et al.
Publicado: (2023) -
Combretastatin-Inspired Heterocycles as Antitubulin
Anticancer Agents
por: Hura, Neha, et al.
Publicado: (2018)